640 related articles for article (PubMed ID: 31393858)
1. Dual peroxisome-proliferator-activated-receptor-α/γ activation inhibits SIRT1-PGC1α axis and causes cardiac dysfunction.
Kalliora C; Kyriazis ID; Oka SI; Lieu MJ; Yue Y; Area-Gomez E; Pol CJ; Tian Y; Mizushima W; Chin A; Scerbo D; Schulze PC; Civelek M; Sadoshima J; Madesh M; Goldberg IJ; Drosatos K
JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31393858
[TBL] [Abstract][Full Text] [Related]
2. Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor
Shizu R; Otsuka Y; Ezaki K; Ishii C; Arakawa S; Amaike Y; Abe T; Hosaka T; Sasaki T; Kanno Y; Miyata M; Yamazoe Y; Yoshinari K
Mol Pharmacol; 2020 Nov; 98(5):634-647. PubMed ID: 32892155
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.
Cha DR; Zhang X; Zhang Y; Wu J; Su D; Han JY; Fang X; Yu B; Breyer MD; Guan Y
Diabetes; 2007 Aug; 56(8):2036-45. PubMed ID: 17536062
[TBL] [Abstract][Full Text] [Related]
4. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
[TBL] [Abstract][Full Text] [Related]
5. Melatonin prevents Drp1-mediated mitochondrial fission in diabetic hearts through SIRT1-PGC1α pathway.
Ding M; Feng N; Tang D; Feng J; Li Z; Jia M; Liu Z; Gu X; Wang Y; Fu F; Pei J
J Pineal Res; 2018 Sep; 65(2):e12491. PubMed ID: 29575122
[TBL] [Abstract][Full Text] [Related]
6. Shengmai San Alleviates Diabetic Cardiomyopathy Through Improvement of Mitochondrial Lipid Metabolic Disorder.
Tian J; Tang W; Xu M; Zhang C; Zhao P; Cao T; Shan X; Lu R; Guo W
Cell Physiol Biochem; 2018; 50(5):1726-1739. PubMed ID: 30384366
[TBL] [Abstract][Full Text] [Related]
7. The Glitazars Paradox: Cardiotoxicity of the Metabolically Beneficial Dual PPARα and PPARγ Activation.
Kalliora C; Drosatos K
J Cardiovasc Pharmacol; 2020 Nov; 76(5):514-526. PubMed ID: 33165133
[TBL] [Abstract][Full Text] [Related]
8. N1‑methylnicotinamide ameliorates insulin resistance in skeletal muscle of type 2 diabetic mice by activating the SIRT1/PGC‑1α signaling pathway.
Chen Y; Zhang J; Li P; Liu C; Li L
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33576435
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide riboside promotes Mfn2-mediated mitochondrial fusion in diabetic hearts through the SIRT1-PGC1α-PPARα pathway.
Hu L; Guo Y; Song L; Wen H; Sun N; Wang Y; Qi B; Liang Q; Geng J; Liu X; Fu F; Li Y
Free Radic Biol Med; 2022 Apr; 183():75-88. PubMed ID: 35318101
[TBL] [Abstract][Full Text] [Related]
10. [Peroxisome proliferator-activated receptor α/γ agonist tesaglitazar stabilizes atherosclerotic plaque in diabetic low density lipoprotein receptor knockout mice].
Zhang BC; Li XK; Che WL; Li WM; Hou L; Wei YD; Xu YW
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Feb; 41(2):143-9. PubMed ID: 23710746
[TBL] [Abstract][Full Text] [Related]
11. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
[TBL] [Abstract][Full Text] [Related]
12. P633H, a novel dual agonist at peroxisome proliferator-activated receptors alpha and gamma, with different anti-diabetic effects in db/db and KK-Ay mice.
Chen W; Zhou XB; Liu HY; Xu C; Wang LL; Li S
Br J Pharmacol; 2009 Jul; 157(5):724-35. PubMed ID: 19422369
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation.
Fang WJ; Wang CJ; He Y; Zhou YL; Peng XD; Liu SK
Acta Pharmacol Sin; 2018 Jan; 39(1):59-73. PubMed ID: 28770830
[TBL] [Abstract][Full Text] [Related]
14. Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving 'SIRT1 and PGC-1α'.
Waldman M; Cohen K; Yadin D; Nudelman V; Gorfil D; Laniado-Schwartzman M; Kornwoski R; Aravot D; Abraham NG; Arad M; Hochhauser E
Cardiovasc Diabetol; 2018 Aug; 17(1):111. PubMed ID: 30071860
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of Acyl-coA thioesterase 1 on diabetic heart via PPARα/PGC1α signaling.
Yang S; Chen C; Wang H; Rao X; Wang F; Duan Q; Chen F; Long G; Gong W; Zou MH; Wang DW
PLoS One; 2012; 7(11):e50376. PubMed ID: 23226270
[TBL] [Abstract][Full Text] [Related]
16. NPY
Wittrisch S; Klöting N; Mörl K; Chakaroun R; Blüher M; Beck-Sickinger AG
Mol Metab; 2020 Jan; 31():163-180. PubMed ID: 31918918
[TBL] [Abstract][Full Text] [Related]
17. Honokiol regulates mitochondrial substrate utilization and cellular fatty acid metabolism in diabetic mice heart.
Jayakumari NR; Rajendran RS; Sivasailam A; Parambil ST; Reghuvaran AC; Sreelatha HV; Gopala S
Eur J Pharmacol; 2021 Apr; 896():173918. PubMed ID: 33529726
[TBL] [Abstract][Full Text] [Related]
18. MD001, a Novel Peroxisome Proliferator-activated Receptor α/γ Agonist, Improves Glucose and Lipid Metabolism.
Kim SH; Hong SH; Park YJ; Sung JH; Suh W; Lee KW; Jung K; Lim C; Kim JH; Kim H; Park KS; Park SG
Sci Rep; 2019 Feb; 9(1):1656. PubMed ID: 30733541
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome Proliferator Activated Receptor-α Association With Silent Information Regulator 1 Suppresses Cardiac Fatty Acid Metabolism in the Failing Heart.
Oka S; Zhai P; Yamamoto T; Ikeda Y; Byun J; Hsu CP; Sadoshima J
Circ Heart Fail; 2015 Nov; 8(6):1123-32. PubMed ID: 26443578
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyocyte-specific loss of RNA polymerase II subunit 5-mediating protein causes myocardial dysfunction and heart failure.
Zhang J; Sheng J; Dong L; Xu Y; Yu L; Liu Y; Huang X; Wan S; Lan HY; Wang H
Cardiovasc Res; 2019 Sep; 115(11):1617-1628. PubMed ID: 30590389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
